- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Sustainable Track Record
Global Pharmaceuticals & Biotech Sustainable Track Record
UPDATED Apr 22, 2024
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
71 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
690 | HK$0.083 | -3.5% | 53.7% | HK$511.6m | n/a | PE7.2x | n/a | n/a | ||
NOVO B | kr.875.30 | -0.4% | 51.8% | kr.3.9t | kr.904.20 | PE46.7x | E14.8% | 1.1% | ||
500420 | ₹2,590.70 | 2.8% | 59.8% | ₹876.8b | ₹2,728.41 | PE58.7x | E21.3% | 1.2% | ||
GLS | ₹839.55 | 6.1% | 80.1% | ₹102.9b | ₹859.00 | PE19.8x | E11.2% | 2.7% | ||
500660 | ₹1,948.10 | 2.4% | 55.4% | ₹330.0b | ₹2,141.25 | PE62.4x | E21.1% | 1.6% | ||
524742 | ₹1,334.60 | 2.9% | 103.4% | ₹101.4b | ₹1,579.33 | PE23.2x | E1.0% | 0.4% | ||
3933 | HK$9.34 | -4.9% | 48.0% | HK$17.0b | HK$12.12 | PE5.8x | E-0.04% | 6.0% | ||
A290650 | ₩20,250.00 | -0.7% | -30.2% | ₩459.4b | n/a | PE9.5x | n/a | 0.5% | ||
301089 | CN¥37.43 | -0.05% | -47.6% | CN¥4.7b | n/a | PE9.7x | n/a | 1.1% | ||
300896 | CN¥283.54 | -3.8% | -45.0% | CN¥61.0b | CN¥449.26 | PE32.8x | E24.6% | 1.6% | ||
IBT | CA$1.44 | 0% | 73.5% | CA$35.3m | n/a | PE8.9x | n/a | n/a | ||
500488 | ₹26,261.45 | 0.3% | 16.6% | ₹558.0b | ₹27,670.43 | PE48.7x | E13.2% | 1.2% | ||
INNOVACAP | ₹471.55 | -2.9% | n/a | ₹27.0b | n/a | PE32.6x | n/a | n/a | ||
CTE | AU$0.81 | 17.4% | 11.0% | AU$39.5m | n/a | PE25.1x | n/a | 1.9% | ||
6472 | NT$718.00 | -9.7% | 28.6% | NT$72.7b | NT$865.00 | PE24x | E22.9% | 1.7% | ||
1681 | HK$5.57 | -1.6% | 14.4% | HK$4.4b | HK$7.87 | PE5.2x | E14.4% | 10.8% | ||
RPGLIFE | ₹1,520.10 | 1.2% | 87.8% | ₹25.1b | n/a | PE29.7x | n/a | 0.8% | ||
6712 | NT$200.50 | -4.1% | 1.6% | NT$14.7b | n/a | PE27.3x | n/a | 1.7% | ||
600129 | CN¥33.90 | 2.5% | -21.4% | CN¥18.9b | CN¥52.83 | PE23x | E22.9% | 0.9% | ||
PBYI | US$5.17 | 1.4% | 90.1% | US$249.2m | US$4.33 | PE11.5x | E-53.5% | n/a | ||
2160 | JP¥2,485.00 | -6.2% | 139.9% | JP¥123.9b | JP¥4,100.00 | PE15.3x | E24.9% | n/a | ||
AJANTPHARM | ₹2,091.35 | -1.2% | 62.5% | ₹263.3b | ₹2,271.20 | PE35.8x | E18.0% | 1.7% | ||
BMY | US$49.14 | 1.8% | -30.0% | US$99.6b | US$56.20 | PE12.4x | E7.8% | 4.9% | ||
ELTP | US$0.13 | -6.0% | 264.5% | US$135.9m | n/a | PE8.7x | n/a | n/a |